Source:http://linkedlifedata.com/resource/pubmed/id/12765449
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2003-5-26
|
pubmed:abstractText |
In drug refractory and highly symptomatic atrial fibrillation (AF) patients, hemodynamic effects of AV node ablation and pacing therapy (APT) were evaluated. Thirty-eight patients with drug refractory and symptomatic AF, underwent APT in eight centers in Japan. The outcome of this therapy was assessed in terms of quality-of-life, cardiac performance measured by echocardiogram, and plasma ANP and BNP levels before and after APT. Quality-of-life assessed by self-administered semi-quantitative questionnaires: WHO QOL 26 (3.0 +/- 0.5 vs 3.4 +/- 0.6, P < 0.01) and the Symptom Checklist: Frequency Scale (1.6 +/- 0.6 vs 0.7 +/- 0.7, P < 0.01) and Severity Scale (1.3 +/- 0.4 vs 0.6 +/- 0.6, P < 0.01), improved significantly 6 months after APT. Ejection fraction (EF) by echocardiogram improved 1 week after APT (59.0% +/- 13.3% vs 63.3% +/- 11.6%, P = 0.02). Plasma ANP levels in the group of ANP > 40 pg/mL at enrollment significantly decreased 1 month later (P = 0.03), and plasma BNP levels in the group of BNP > 20 pg/mL at enrollment significantly decreased 1 month later (P < 0.01). In conclusion, APT has beneficial hemodynamic effects, and plasma BNP levels can predict the most optimal candidates for ablation and pacing therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0147-8389
|
pubmed:author |
pubmed-author:Ablation and Pacing Therapy Working Group,
pubmed-author:HaradaTomooT,
pubmed-author:IesakaYoshitoY,
pubmed-author:ItoHiroshiH,
pubmed-author:KumagaiKoichiroK,
pubmed-author:MitsuhashiTakeshiT,
pubmed-author:NittaJunichiJ,
pubmed-author:NurukiNorihitoN,
pubmed-author:ShiraishiTakayoshiT,
pubmed-author:ShirotaKinyaK,
pubmed-author:TakahashiAtsushiA,
pubmed-author:TakahashiYoshihideY
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1212-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12765449-Aged,
pubmed-meshheading:12765449-Atrial Fibrillation,
pubmed-meshheading:12765449-Atrial Natriuretic Factor,
pubmed-meshheading:12765449-Atrioventricular Node,
pubmed-meshheading:12765449-Catheter Ablation,
pubmed-meshheading:12765449-Echocardiography,
pubmed-meshheading:12765449-Female,
pubmed-meshheading:12765449-Hemodynamics,
pubmed-meshheading:12765449-Humans,
pubmed-meshheading:12765449-Male,
pubmed-meshheading:12765449-Natriuretic Peptide, Brain,
pubmed-meshheading:12765449-Pacemaker, Artificial,
pubmed-meshheading:12765449-Quality of Life,
pubmed-meshheading:12765449-Statistics, Nonparametric,
pubmed-meshheading:12765449-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
AV nodal ablation and pacemaker implantation improves hemodynamic function in atrial fibrillation.
|
pubmed:affiliation |
Cardiovascular Division, Tsuchiura Kyoudo Hospital, Tokyo, Japan. yoshit@tf6.so-net.ne.jp
|
pubmed:publicationType |
Journal Article
|